Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Monique Landry"'
Autor:
Marilou Kiely, Nicole Boulianne, Denis Talbot, Manale Ouakki, Maryse Guay, Monique Landry, Chantal Sauvageau, Gaston De Serres
Publikováno v:
BMC Public Health, Vol 18, Iss 1, Pp 1-15 (2018)
Abstract Background Timeliness in the administration of recommended vaccines is often evaluated using vaccine delays and provides more information regarding the susceptibility of children to vaccine-preventable diseases compared with vaccine coverage
Externí odkaz:
https://doaj.org/article/b3fbf9fe4e6a47b7935b753e2907b49f
Autor:
Eve Dubé, Dominique Gagnon, Denis Hamel, Sylvie Belley, Hélène Gagné, Nicole Boulianne, Monique Landry, Julie A Bettinger
Publikováno v:
Canadian Journal of Infectious Diseases and Medical Microbiology, Vol 26, Iss 3, Pp 163-167 (2015)
A mass vaccination campaign with the 4CMenB vaccine (Bexsero®; Novartis Pharmaceutical Canada Inc) was launched in a serogroup B endemic area in Quebec. A telephone survey was conducted to assess parental and adolescent opinions about the acceptabil
Externí odkaz:
https://doaj.org/article/37748bdde4e24dc9a666dd343c7c1cff
Autor:
Marie-Noëlle Billard, Gaston De Serres, Marie-Claude Gariépy, Nicole Boulianne, Eveline Toth, Monique Landry, Danuta M Skowronski
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186070 (2017)
A large measles outbreak occurred in Quebec, Canada, in 2011. Although nearly two-thirds of the cases occurred in only two health districts, a mass vaccination campaign targeting all Quebec elementary and high school students without valid two-dose h
Externí odkaz:
https://doaj.org/article/6bb12650979e4a42a2b1efadf691d7be
Autor:
Nicole Boulianne, Monique Landry, Marilou Kiely, Denis Talbot, Gaston De Serres, Manale Ouakki, Maryse Guay, Chantal Sauvageau
Publikováno v:
Vaccine. 38:1202-1210
Background Monitoring vaccination coverage is an essential component of vaccination program evaluation. In Quebec (Canada), children vaccination coverage surveys are conducted every two years since 2006. The objectives of this study were to evaluate
Autor:
Marie-Claude Roy, Sylvie Belley, Gaston De Serres, Eveline Toth, Danuta M. Skowronski, Monique Landry, Hélène Gagné, Marie-Noëlle Billard, François D. Boucher, Marie-Claude Gariépy
Publikováno v:
Vaccine. 37:4996-5002
Background In May 2014, a mass vaccination campaign with four-component meningococcal serogroup B (4CMenB) vaccine was launched in a localized region of Quebec, Canada experiencing high invasive meningococcal B disease endemicity. Active post-marketi
Autor:
Chantal Sauvageau, Monique Landry, Maryse Guay, Manale Ouakki, Nicole Boulianne, Gaston De Serres, Denis Talbot, Marilou Kiely
Publikováno v:
BMC Public Health, Vol 18, Iss 1, Pp 1-15 (2018)
BMC Public Health
BMC Public Health
Background Timeliness in the administration of recommended vaccines is often evaluated using vaccine delays and provides more information regarding the susceptibility of children to vaccine-preventable diseases compared with vaccine coverage at a giv
Autor:
Chantal Sauvageau, Maryse Guay, Nicole Boulianne, Monique Landry, Manale Ouakki, Marilou Kiely, Denis Talbot, Joseline G. Zafack, Gaston De Serres
Publikováno v:
Vaccine. 36:4383-4391
Context Between 2004 and 2016, in the province of Quebec (Canada), 4 new antigens were added in the early childhood vaccine schedule from birth to 18 months, increasing the number of injections or doses needed from 7 to 12. These additions may have d
Autor:
Julie A. Bettinger, Nicole Boulianne, Monique Landry, Manale Ouakki, Eve Dubé, Hélène Gagné, Dominique D. Gagnon, Sylvie Belley
Publikováno v:
Vaccine Reports. 6:29-35
A mass vaccination campaign with the 4CMenB vaccine (Bexsero®) was launched in a serogroup B endemic area in Quebec. A study was conducted to assess parents’ and adolescents’ opinions about the acceptability of the vaccine before and after the c
Autor:
Monique Landry, Jean-Philippe Drolet, Eveline Toth, Gaston De Serres, Karina A. Top, Joseline G. Zafack
Publikováno v:
The Pediatric infectious disease journal. 38(4)
While adverse events following immunization (AEFI) are frequent, there are limited data on the safety of reimmunizing patients who had a prior AEFI. Our objective was to estimate the rate and severity of AEFI recurrences.We analyzed data from the AEF
Autor:
Danuta M. Skowronski, Manale Ouakki, Isabelle Rouleau, Hélène Gagné, Gaston De Serres, Marie-Noëlle Billard, Eveline Toth, Geneviève Deceuninck, Monique Landry, Vladimir Gilca, Nicole Boulianne, Marie-Claude Gariépy
Publikováno v:
Vaccine. 36(52)
BACKGROUND To address a high incidence of serogroup B invasive meningococcal disease (IMD-B) in the Saguenay-Lac-Saint-Jean region, Quebec, Canada, a mass vaccination campaign targeting nearly 60,000 individuals ≤20 years old was launched in May 20